100 years of pyrazolone drugs
Schadewaldt, H.
Agents and Actions. Supplements 19: 341-355
1986
ISSN/ISBN: 0379-0363 PMID: 3529886 Document Number: 277369
Document emailed within 1 workday
Related Documents
Wong, I.C. 1997: New antiepileptic drugs. Study suggests that under a quarter of patients will still be taking the new drugs after six years Bmj 314(7080): 603-604Maucher, O.M.; Fuchs, A. 1983: Contact urticaria caused by skin test in pyrazolone allergy Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 34(8): 383-386
Cuenca, R.; Cierco, P.; San José, A.; Bosch, J.A. 1989: Pyrazolone-induced agranulocytosis, consumption coagulopathy and acute pancreatitis Medicina Clinica 92(15): 596
Bien, E. 1983: Effect of pyrazolone derivatives on the level of reduced glutathione in rat liver Biomedica Biochimica Acta 42(5): 561-571
Górniak, H. 1974: Determination of Co(II) in pharmaceutical preparations by means of 1-thiocarbamoyl-3-methyl-5-pyrazolone Acta Poloniae Pharmaceutica 31(4): 473-479
Golikov, P.P.; Nikolaeva, N.I.; Kladiev, A.A. 1989: The activation of specific type-IIi glucocorticoid receptors by pyrazolone series preparations Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 4: 19-22
Dizhenina, I.I. 1983: Anticoagulant properties of the electrophoresis of pyrazolone preparations in ischemic heart disease Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 3: 47-50
Mokhort, N.A.; Trinus, F.P. 1971: Effect of anthranilic and salicylic acid derivatives and pyrazolone on the course of experimental ulcers of the gastric mucosa Vrachebnoe Delo 6: 17-21
Viala, A.; Paulin, R.; Cano, J.P.; Durand, A.; Placidi, M.; Roux, F.; Lefournier, C. 1976: A comparative study in the rat of two routes of administration of 14 c-labeled sodium m-trifluoromethyl-1, 3-diphenyl-4-hydroxymethylene-5-pyrazolone Therapie 31(4): 541-555
Weiss, R.; Brauer, J.; Goertz, U.; Petry, R. 1974: Comparative study on the problem of absorption and metabolism of the pyrazolone derivative metamizole, in man after oral and intramuscular administration Arzneimittel-Forschung 24(3): 345-348
Jérôme, R. 1988: The systematic reporting of drugs is 50 years old Orvosi Hetilap 129(16): 841-842
Novácek, L. 1984: 100 years of development of chemical drugs Ceskoslovenska Farmacie 33(10): 444-447
Andrew, M.; Toverud, E.L. 1990: Prescription of drugs in Norway to children aged 0-12 years Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 110(25): 3215-3219
Drozd, M. 2002: Evaluation of accessibility to drugs for patients in the years 1996-2001 Wiadomosci Lekarskie 55 Suppl. 1(Pt 2): 651-654
Murstein, B.I.; Mercy, T. 1994: Sex, drugs, relationships, contraception, and fears of disease on a college campus over 17 years Adolescence 29(114): 303-322
König, A.; Reincke, M. 2008: 25 years of progress in endocrinology: treating with drugs instead of mutilating the pituitary gland MMW Fortschritte der Medizin 150(48): 74 76 78
Khaburova, T.L. 2012: Dynamics of frequency of prescriptions of some psychotropic drugs for 50 years (pharmacoepidemiological study) Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 112(2): 59-63
van der Merwe, P.J.; Kruger, H.S. 1992: Drugs in sport--results of the past 6 years of dope testing in South Africa South African Medical Journal 82(3): 151-153
Higgs, G. 2003: After 100 years of aspirin, the anticytokine drugs offer a new approach to anti-inflammatory therapy Current Opinion in Investigational Drugs 4(5): 517-518
Tan, W.C.; Ong, C.K.; Kang, S.C.L.; Razak, M.A. 2007: Two years review of cutaneous adverse drug reaction from first line anti-tuberculous drugs Medical Journal of Malaysia 62(2): 143-146